Overview

Archimedes Pharma markets a diverse portfolio of specialty products focused on the oncology, pain, and critical care sectors in the US and throughout Europe.

A key part of delivering the vision is establishing dynamic high quality sales and marketing operations in major markets and Archimedes Pharma has established commercial organizations in the UK, US, France, Germany, Ireland, and Spain. Since 2004, Archimedes Pharma has been growing its commercial presence through the acquisition of a range of speciality products and technologies together with a commercial pharmaceutical platform. The company continues to expand its operations to include in–house development of products based on its proprietary drug delivery technologies.

To learn more about the company’s country operations, select the country you would like more information about.